These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38850301)

  • 1. Population pharmacokinetics of fluconazole for prevention or treatment of invasive candidiasis in Chinese young infants.
    Wang H; Li D; Jiang Y; Liang J; Yu Q; Kuang L; Huang Y; Qin D; Li P; He J; Xu F; Li X; Wang F; Wei Y; Li X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Nov; 397(11):8853-8862. PubMed ID: 38850301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of fluconazole in young infants.
    Wade KC; Wu D; Kaufman DA; Ward RM; Benjamin DK; Sullivan JE; Ramey N; Jayaraman B; Hoppu K; Adamson PC; Gastonguay MR; Barrett JS;
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4043-9. PubMed ID: 18809946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.
    Momper JD; Capparelli EV; Wade KC; Kantak A; Dhanireddy R; Cummings JJ; Nedrelow JH; Hudak ML; Mundakel GT; Natarajan G; Gao J; Laughon M; Smith PB; Benjamin DK
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5539-45. PubMed ID: 27401564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.
    Wade KC; Benjamin DK; Kaufman DA; Ward RM; Smith PB; Jayaraman B; Adamson PC; Gastonguay MR; Barrett JS
    Pediatr Infect Dis J; 2009 Aug; 28(8):717-23. PubMed ID: 19593252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation.
    Watt KM; Gonzalez D; Benjamin DK; Brouwer KL; Wade KC; Capparelli E; Barrett J; Cohen-Wolkowiez M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3935-43. PubMed ID: 25896706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Study of Prophylactic Fluconazole in Preterm Infants for Prevention of Invasive Candidiasis.
    Kim YK; Lee J; Oh J; Rhee SJ; Shin SH; Yoon SH; Lee S; Kim HS; Yu KS
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants.
    Tanzawa A; Saito J; Shoji K; Kojo Y; Funaki T; Maruyama H; Isayama T; Ito Y; Nakamura H; Yamatani A
    Microbiol Spectr; 2022 Apr; 10(2):e0195221. PubMed ID: 35266811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of fluconazole therapy for the treatment of invasive candidiasis in preterm infants.
    Engbers AGJ; Flint RB; Voeller S; Reiss I; Liem KD; Alffenaar JC; Tibboel D; Simons S; Knibbe CAJ; Brüggemann RJ
    Arch Dis Child; 2022 Apr; 107(4):400-406. PubMed ID: 35074829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
    Gharibian KN; Mueller BA
    Clin Nephrol; 2016 Jul; 86(7):43-50. PubMed ID: 27251341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
    Patel K; Roberts JA; Lipman J; Tett SE; Deldot ME; Kirkpatrick CM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5868-73. PubMed ID: 21930888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial.
    Leroux S; Jacqz-Aigrain E; Elie V; Legrand F; Barin-Le Guellec C; Aurich B; Biran V; Dusang B; Goudjil S; Coopman S; Garcia Sanchez R; Zhao W; Manzoni P;
    Br J Clin Pharmacol; 2018 Sep; 84(9):1989-1999. PubMed ID: 29744900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole loading dose pharmacokinetics and safety in infants.
    Piper L; Smith PB; Hornik CP; Cheifetz IM; Barrett JS; Moorthy G; Hope WW; Wade KC; Cohen-Wolkowiez M; Benjamin DK
    Pediatr Infect Dis J; 2011 May; 30(5):375-8. PubMed ID: 21085048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
    Cojutti PG; Lugano M; Righi E; Della Rocca G; Bassetti M; Hope W; Pea F
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1449-1459. PubMed ID: 30032414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.
    Aoyama T; Hirata K; Hirata R; Yamazaki H; Yamamoto Y; Hayashi H; Matsumoto Y
    J Clin Pharm Ther; 2012 Jun; 37(3):356-63. PubMed ID: 21883330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
    Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
    Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants.
    Cohen-Wolkowiez M; Ouellet D; Smith PB; James LP; Ross A; Sullivan JE; Walsh MC; Zadell A; Newman N; White NR; Kashuba AD; Benjamin DK
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1828-37. PubMed ID: 22252819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation.
    Watt KM; Benjamin DK; Cheifetz IM; Moorthy G; Wade KC; Smith PB; Brouwer KL; Capparelli EV; Cohen-Wolkowiez M
    Pediatr Infect Dis J; 2012 Oct; 31(10):1042-7. PubMed ID: 22627870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis.
    Li X; Qi H; Jin F; Yao BF; Wu YE; Qi YJ; Kou C; Wu XR; Luo XJ; Shen YH; Zheng X; Wang YH; Xu F; Jiao WW; Li JQ; Xiao J; Dong YN; Du B; Shi HY; Xu BP; Shen AD; Zhao W
    Eur J Pharm Sci; 2021 Aug; 163():105868. PubMed ID: 33951483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis.
    Wu YE; Kou C; Li X; Tang BH; Yao BF; Hao GX; Zheng Y; van den Anker J; You DP; Shen AD; Zhao W
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.
    Kovanda LL; Walsh TJ; Benjamin DK; Arrieta A; Kaufman DA; Smith PB; Manzoni P; Desai AV; Kaibara A; Bonate PL; Hope WW
    Pediatr Infect Dis J; 2018 Jun; 37(6):580-585. PubMed ID: 29762386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.